Barnett & Company’s Zoetis ZTS Stock Holding History

Barnett & Company’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30	Closed	-$7K	–	279
2021 Q4	$7K	Buy	+30	New	+$6.57K	﹤0.01%	216

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Barnett & Company's ZTS Position: Q1 2022 in Review

Barnett & Company sold out of Zoetis (ZTS) in Q1 2022, closing a stake of 30 shares — an estimated $7K sold.

Barnett & Company first reported a position in ZTS in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 1,637 funds tracked by Wall St. Rank hold ZTS as of Q1 2022.

Barnett & Company reported no remaining Zoetis position as of Q1 2022 after selling out during the quarter.
Barnett & Company sold 30 Zoetis shares in Q1 2022, an estimated $7K.
Barnett & Company first reported a position in Zoetis in Q4 2021 and held it in 1 quarter.
Barnett & Company's Zoetis position peaked at $7K in Q4 2021.
1,637 funds tracked by Wall St. Rank held Zoetis as of Q1 2022.

Based on Barnett & Company's 13F filing for Q1 2022, filed 28 Apr 2022.